Shanghai Yizhong Pharmaceutical Co., Ltd.

SHSE:688091 Stock Report

Mkt Cap: CN¥11.3b

Shanghai Yizhong Pharmaceutical Past Performance

Past criteria checks 3/6

Shanghai Yizhong Pharmaceutical has been growing earnings at an average annual rate of 90.8%, while the Pharmaceuticals industry saw earnings growing at 8.8% annually. Revenues have been growing at an average rate of 665.3% per year. Shanghai Yizhong Pharmaceutical's return on equity is 12.1%, and it has net margins of 56.8%.

Key information


Earnings growth rate


EPS growth rate

Pharmaceuticals Industry Growth8.8%
Revenue growth rate665.3%
Return on equity12.1%
Net Margin56.8%
Last Earnings Update31 Mar 2023

Recent past performance updates

No updates

Recent updates

Earnings and Revenue History

Quality Earnings: 688091 has a high level of non-cash earnings.

Growing Profit Margin: 688091's current net profit margins (56.8%) are lower than last year (83.9%).

Past Earnings Growth Analysis

Earnings Trend: 688091 has become profitable over the past 5 years, growing earnings by 90.8% per year.

Accelerating Growth: 688091's earnings growth over the past year (418.2%) exceeds its 5-year average (90.8% per year).

Earnings vs Industry: 688091 earnings growth over the past year (418.2%) exceeded the Pharmaceuticals industry 15.3%.

Return on Equity

High ROE: 688091's Return on Equity (12.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies